Vaxcyte (PCVX) Earnings Date, Estimates & Call Transcripts $29.90 -0.11 (-0.37%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$29.92 +0.02 (+0.05%) As of 08/8/2025 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vaxcyte Earnings Summary Vaxcyte released Q2 2025 earnings on August 6, 2025, reporting an EPS of -$1.22, which missed the consensus estimate of -$1.12 by $0.10. With a trailing EPS of -$4.11, Vaxcyte's earnings are expected to decrease next year, from ($4.21) to ($4.49) per share. Latest Q2 Earnings DateAug. 6EstimatedConsensus EPS (Aug. 6) -$1.12 Actual EPS (Aug. 6) -$1.22 Missed By -$0.10 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)Powered by Get Vaxcyte Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vaxcyte and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataPCVX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Vaxcyte Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$1.07-$1.07-$1.07Q2 20251-$1.18-$1.18-$1.18Q3 20251-$1.47-$1.47-$1.47Q4 20251-$1.50-$1.50-$1.50 Vaxcyte Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails8/6/2025Q2 2025-$1.12-$1.22 -$0.10-$1.22--5/14/2025Q1 2025-$1.02-$1.04 -$0.02-$1.04--2/25/2025Q4 2024-$1.16-$1.02+$0.14-$1.02--11/5/2024Q3 2024-$1.10-$0.83+$0.27-$0.83--8/6/2024Q2 2024-$1.14-$1.10+$0.04-$1.10--5/8/2024Q1 2024-$1.13-$0.85+$0.28-$0.85--2/27/2024Q4 2023-$0.89-$1.82 -$0.93-$1.82--11/6/2023Q3 2023-$0.84-$0.91 -$0.07-$0.91-- Vaxcyte Earnings - Frequently Asked Questions When did Vaxcyte announce their last quarterly earnings? Vaxcyte (NASDAQ:PCVX) last announced its quarterly earning data on Wednesday, August 6, 2025. Learn more on PCVX's earnings history. Did Vaxcyte beat their earnings estimates last quarter? In the previous quarter, Vaxcyte (NASDAQ:PCVX) missed the analysts' consensus estimate of ($1.12) by $0.10 with a reported earnings per share (EPS) of ($1.22). Learn more on analysts' earnings estimate vs. PCVX's actual earnings. How much profit does Vaxcyte generate each year? Vaxcyte (NASDAQ:PCVX) has a recorded net income of -$463.93 million. PCVX has generated -$4.11 earnings per share over the last four quarters. What is Vaxcyte's EPS forecast for next year? Vaxcyte's earnings are expected to decrease from ($4.21) per share to ($4.49) per share in the next year. More Earnings Resources from MarketBeat Related Companies GMAB Earnings Date RDY Earnings Date ASND Earnings Date QGEN Earnings Date MRNA Earnings Date VTRS Earnings Date BBIO Earnings Date VRNA Earnings Date BPMC Earnings Date ROIV Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Airbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a Rally This page (NASDAQ:PCVX) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe stealth altcoin the financial world is underestimatingThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaxcyte, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaxcyte With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
